Keyphrases
Accuracy Rate
25%
AE-IPF
100%
Anatomical Information
25%
Artificial Intelligence Models
20%
Automated Classification
100%
Background Pattern
25%
Benign Nodule
100%
Bronchoscopy
25%
Classification Accuracy
25%
Classification Performance
25%
Classification Scheme
25%
Clinician Feedback
20%
Computed Tomography
25%
Computed Tomography Examination
25%
Computed Tomography Images
25%
Conventional CT
50%
COVID-19
100%
CT Images
75%
Delayed Phase
50%
Dyspnea
25%
Functional Information
25%
Functional Traits
25%
Ground-glass Opacity
50%
High-dose Steroids
100%
Lung Biopsy
25%
Lymphocyte Profile
100%
Machine Learning Techniques
25%
Malignancy
25%
Malignant Nodules
50%
Mediastinal Lymphadenopathy
100%
Methylprednisolone
25%
New Scenario
20%
Nodule Detection
25%
Non-image Data
100%
Older Women
25%
Pandemic Situation
20%
PET Image
50%
Polymerase Chain Reaction Assay
25%
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Pulmonary Infiltrates
25%
Pulmonary Nodule
100%
Random Forest Algorithm
25%
Retrospective Analysis
100%
Severe Disabilities
25%
Shape Features
25%
Standardized Uptake Value
25%
Subjective Judgments
25%
Successful Treatment
100%
Treatment Options
25%
Usual Interstitial Pneumonia
25%
Medicine and Dentistry
Airflow
50%
Asthma
100%
Bronchial Thermoplasty
100%
Bronchodilating Agent
16%
Cohort Study
16%
Computer Assisted Tomography
25%
COVID-19
100%
Drug Megadose
100%
Drug Therapy
16%
Dyspnea
25%
Forced Expiratory Volume
33%
Ground Glass Opacity
50%
Idiopathic Pulmonary Fibrosis
100%
Intelligence
16%
Mediastinal Lymphadenopathy
100%
Medical Record
16%
Methylprednisolone
25%
Polymerase Chain Reaction
25%
Pulmonary Infiltrate
25%
Respiratory Failure
100%
Severe Asthma
16%
Usual Interstitial Pneumonia
25%
Immunology and Microbiology
Airflow
50%
Asthma
100%
Bronchial Thermoplasty
100%
Bronchodilator
16%
Computer Assisted Tomography
25%
Decision Making
25%
Forced Expiratory Volume
33%
Medical Record
16%
Pet Animal
100%
Positron Emission Tomography-Computed Tomography
100%
Random Forest
25%
Severe Asthma
16%